Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial
Titel:
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial
Auteur:
Felip, E. Altorki, N. Zhou, C. Vallières, E. Martínez-Martí, A. Rittmeyer, A. Chella, A. Reck, M. Goloborodko, O. Huang, M. Belleli, R. McNally, V. Srivastava, M.K. Bennett, E. Gitlitz, B.J. Wakelee, H.A.